Compare Corona Remedies with Similar Stocks
Loading Valuation Snapshot...
Stock DNA
Pharmaceuticals & Biotechnology
INR 9,822 Cr (Small Cap)
48.00
32
0.00%
-0.01
24.61%
15.80
Revenue and Profits:
Net Sales:
342 Cr
(Quarterly Results - Dec 2025)
Net Profit:
41 Cr
Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
17.42%
0%
17.42%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Corona Remedies for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
19.13
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.86
Tax Ratio
24.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.60%
ROCE (avg)
29.97%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
48
Industry P/E
32
Price to Book Value
15.88
EV to EBIT
47.41
EV to EBITDA
40.07
EV to Capital Employed
16.05
EV to Sales
8.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
33.85%
ROE (Latest)
24.61%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
KST
Dow Theory
No Trend
OBV
No Trend
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 13 Schemes (6.38%)
FIIs
Held by 18 FIIs (1.84%)
Promoter with highest holding
Ankurbhai K Mehta (22.0%)
Highest Public shareholder
Sepia Investments Limited (19.76%)
Individual Investors Holdings
1.36%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
342.42
361.13
-5.18%
Operating Profit (PBDIT) excl Other Income
83.16
78.47
5.98%
Interest
1.66
1.93
-13.99%
Exceptional Items
-19.10
0.00
Standalone Net Profit
41.25
52.15
-20.90%
Operating Profit Margin (Excl OI)
24.29%
21.73%
2.56%
Values in Rs Cr.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -5.18% vs 4.21% in Sep 2025
Standalone Net Profit
QoQ Growth in quarter ended Dec 2025 is -20.90% vs 12.39% in Sep 2025
About Corona Remedies Ltd 
Corona Remedies Ltd
Small Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






